Report Updates
81-100 of 10756
- 2021.01.07J Trust (8508) Report Update: Post Q3 FY12/20 Earnings Interview
- 2021.01.07SHIFT (3697) Releases Q1 FY08/21 Results
- 2021.01.07SHIFT (3697) announces additional contributions and an extended trust period for the stock-granting ESOP (employee stock ownership plan) trust
- 2021.01.07Takashimaya (8233) Report Update: Post Q3 FY02/21 Earnings Interview
- 2021.01.07Round One (4680) Releases Monthly Sales Data
- 2021.01.07CRE (3458) Report Update: Post Q1 FY07/21 Earnings Interview
- 2021.01.07Kameda Seika (2220) Report Update: Post 1H FY03/21 Earnings Interview
- 2021.01.07SHIKIGAKU (7049) announces monthly sales figures
- 2021.01.06GameWith (6552) Releases 1H FY05/21 Results
- 2021.01.06Fields (2767) announces the nationwide launch of a new pachislot machine, PACHISLOT THE iDOLM@STER MILLION LIVE!
- 2021.01.06Visionary Holdings (9263) Report Update: Post 1H FY04/21 Earnings Interview
- 2021.01.06Nipro (8086) Report Update: Post 1H FY03/21 Earnings Interview
- 2021.01.06i-mobile (6535) Report Update: Post Q1 FY07/21 Earnings Interview
- 2021.01.06Tokyu Construction (1720) Report Update: Post 1H FY03/21 Earnings Interview
- 2021.01.06Round One (4680) announces the decision to open its first store in the People's Republic of China
- 2021.01.06Nichi-Iko Pharmaceutical (4541) announces the additional efficacy and effectiveness of Nalfurafine hydrochloride Capsules 2.5µg “Nichi-Iko” for peritoneal dialysis and chronic liver disease patients
- 2021.01.06Nichi-Iko Pharmaceutical (4541) announces the launch of a joint sales initiative for metabolism activator “Adetphos Kowa Enteric Coated Tablet 20” with Kowa Company, Ltd
- 2021.01.05AI inside (4488) Report Update: Post 1H FY03/21 Earnings Interview
- 2021.01.05JINS Holdings(3046)Releases Monthly Sales Data
- 2021.01.05Ryohin Keikaku (7453) announces monthly sales data